Press Releases

DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with...

DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year ended December 31, 2023. "As we reflect on the past year, our 2023 financial performance highlighted the...

DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Tuesday, February 13, 2024, at 5:00 p.m. Eastern Time. The company...

Due to weather conditions from a widespread winter storm (Jan. 12 – 16, 2024), DaVita centers may be closed or experiencing a delayed start. DaVita’s care teams across the region are working...

Funding to support co-created 'Start Early' program aimed at increasing degree completion rates DENVER, Dec. 19, 2023 /PRNewswire/ -- The DaVita Giving Foundation has awarded Western Governors...

Since 2007, DaVita has raised millions and impacted thousands globally through annual activity-based events DENVER, Nov. 30, 2023 /PRNewswire/ -- DaVita, a leading provider of kidney care...

DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2023. "We delivered another strong quarter," said Javier Rodriguez, CEO of DaVita Inc. "We...

Research includes studies designed to overcome barriers to living donation and in-home treatment among African American and Spanish-speaking Mexican American patients DENVER and PHILADELPHIA, Nov....

DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Tuesday, November 7, 2023, at 5:00 p.m. Eastern Time. The company plans...

DaVita issued the following statement in response to news this week from Novo Nordisk, manufacturer of Ozempic®, a glucagon-like peptide 1 (GLP-1) receptor agonist indicated for type 2 diabetes,...